CORMEDICS

Cormedics Corporation is a medical device company focused on developing novel technologies that selectively treat the entire heart with drug, cell, gene, and device therapies by introduction into the pericardial space. Cormedics Corporation develops medical technologies that focus on putting more control into the hands of those who treat cardiac patients. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes. Cormedics is headquartered in Houston, Texas and has four major focus areas that include: cardiac rhythm management, atrial fibrillation, pericardial effusion, and targeted cardiac drug delivery.